The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats

FEBS Journal

Volumn 278, Issue 9, 2011, Pages 1522-1532

  Li, Wei Qing ^a   Chen, Chao ^a   Xu, Mi Die ^a   Guo, Jia ^b   Li, Yi Ming ^a   Xia, Qing Mei ^c   Liu, Hui Min ^a   He, Jin ^a   Yu, Hong Yu ^a   Zhu, Liang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Shanghai SunBio Medical Biotechnology Co Ltd   (China)

Author keywords

acyl CoA synthetase long chain family member 1 (ACSL1); gene ontology; hepatic fibrosis; miR 34a miR 34c; rat

Indexed keywords

DIMETHYLNITROSAMINE; GREEN FLUORESCENT PROTEIN; MICRORNA; MICRORNA 34A; MICRORNA 34C; MICRORNA 878; RNO MICRORNA 34; UNCLASSIFIED DRUG;

ACSL1 GENE; ACYL COA SYNTHETASE LONG CHAIN FAMILY MEMBER 1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID METABOLISM; GENE; GENE TARGETING; IMMUNOBLOTTING; LIPID METABOLISM; LIVER FIBROSIS; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; COENZYME A LIGASES; DIMETHYLNITROSAMINE; LIVER CIRRHOSIS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

RATTUS;

EID: 79955065145     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08075.x     Document Type: Article

References (41)

1. Friedman SL, (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275, 2247-2250. (Pubitemid 30081976)
2. Gressner AM, &, Weiskirchen R, (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10, 76-99. (Pubitemid 44874293)
3. Bataller R, &, Brenner DA, (2001) Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 21, 437-445.
4. Friedman SL, (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88, 125-172.
5. Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, Tellier Z, Guichard C, Ogier-Denis E, Poynard T, et al. (2007) High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology 46, 1893-1906.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
7. Bala S, Marcos M, &, Szabo G, (2009) Emerging role of microRNAs in liver diseases. World J Gastroenterol 15, 5633-5640.
8. Jiang X, Tsitsiou E, Herrick SE, &, Lindsay MA, (2010) MicroRNAs and the regulation of fibrosis. FEBS J 277, 2015-2021.
9. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, et al. (2010) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-218.
10. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, &, Zern MA, (2010) Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298, G101-G106.
11. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134. (Pubitemid 47014436)
12. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26, 745-752. (Pubitemid 46856245)
13. Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, Liu S, Liu Z, Shi H, Shen H, et al. (2011) A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 128, 412-417.
14. Bataller R, &, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115, 209-218. (Pubitemid 40385459)
15. Friedman SL, (2004) Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 1, 98-105. (Pubitemid 40823677)
16. Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Buttner R, Scholmerich J, &, Hellerbrand C, (2009) Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res 19, 996-1005.
17. Liu X, Hu H, &, Yin JQ, (2006) Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int 26, 8-22.
18. He X, He L, &, Hannon GJ, (2007) The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67, 11099-11101. (Pubitemid 350248530)
19. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, &, Hermeking H, (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593. (Pubitemid 47327945)
20. Welch C, Chen Y, &, Stallings RL, (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017-5022. (Pubitemid 47172643)
21. Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, &, Yeung WS, (2010) MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 31, 1037-1044.
22. Tazawa H, Tsuchiya N, Izumiya M, &, Nakagama H, (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104, 15472-15477. (Pubitemid 47502941)
23. Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J, &, Harris CC, (2008) Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 68, 3193-3203.
24. Fontana L, Moreira E, Torres MI, Periago JL, Sanchez de Medina F, &, Gil A, (1999) Effects of dietary polyunsaturated fatty acids and nucleotides on tissue fatty acid profiles of rats with carbon tetrachloride-induced liver damage. Clin Nutr 18, 93-101. (Pubitemid 29237909)
25. Takahara Y, Takahashi M, Wagatsuma H, Yokoya F, Zhang QW, Yamaguchi M, Aburatani H, &, Kawada N, (2006) Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. World J Gastroenterol 12, 6473-6499. (Pubitemid 44742584)
26. Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, Liang TJ, &, Hoofnagle JH, (2006) Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement. Clin Gastroenterol Hepatol 4, 1048-1052. (Pubitemid 44118842)
27. Farrell GC, &, Larter CZ, (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99-S112.
28. Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Enjoji M, et al. (2008) SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med 21, 507-511. (Pubitemid 351802646)
29. Ruvolo PP, (2003) Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 47, 383-392. (Pubitemid 36379200)
30. Sampath H, &, Ntambi JM, (2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 25, 317-340. (Pubitemid 41209005)
31. Guo CJ, Pan Q, Cheng T, Jiang B, Chen GY, &, Li DG, (2009) Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways. FEBS J 276, 5163-5176.
32. Guo CJ, Pan Q, Jiang B, Chen GY, &, Li DG, (2009) Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis 14, 1331-1340.
33. Guo CJ, Zhang YF, Yang LS, Yang XB, Wu YY, Liu D, Chen WJ, Weng SP, Yu XQ, &, He JG, (2009) The JAK and STAT family members of the mandarin fish Siniperca chuatsi: molecular cloning, tissue distribution and immunobiological activity. Fish Shellfish Immunol 27, 349-359.
34. Ji J, Zhang J, Huang G, Qian J, Wang X, &, Mei S, (2009) Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583, 759-766.
35. Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, &, Kawada N, (2010) Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun 391, 316-321.
36. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, &, Diehl AM, (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366-1374. (Pubitemid 46918320)
37. Abe F, Akimoto H, Akopian A, Albrow MG, Amendolia SR, Amidei D, Antos J, Aota S, Apollinari G, Arisawa T, et al. (2000) Search for a Wâ€2 boson via the decay mode Wâ€2 - >munumu in 1.8 TeV pp collisions. Phys Rev Lett 84, 5716-5721.
38. Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, et al. (2007) Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol 25, 663-668. (Pubitemid 46897203)
39. Schlitt T, Palin K, Rung J, Dietmann S, Lappe M, Ukkonen E, &, Brazma A, (2003) From gene networks to gene function. Genome Res 13, 2568-2576. (Pubitemid 37541145)
40. Livak KJ, &, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. (Pubitemid 34164012)
41. Suzuki Y, Takeda Y, &, Ikuta T, (2008) Immunoblotting conditions for human hemoglobin chains. Anal Biochem 378, 218-220.